Skip to main content
. 2020 Aug 12;295(42):14379–14390. doi: 10.1074/jbc.REV120.008387

Figure 2.

Figure 2.

Two-hit hypothesis for the effect of SGLT2 inhibitors to promote euglycemic ketoacidosis via both predisposing to volume depletion and lowering plasma insulin concentrations.